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INTRODUCTION
The macrofungi - the mushrooms are eukaryotic, non-
photosynthetic, and aerobic organisms that form characteristic 
fruiting bodies. Belonging to the Fifth Kingdom, all mushrooms 
are heterotrophic, and they assimilate nutritive substances by 
absorption of simple molecules as nutrients after complex or-
ganic polymers such as celluloses are degraded by extracellular 
enzymes secreted by them. The mushrooms are taxonomically 
classified in two different groups: Basidiomycetes, which com-
prise many of the known genera and Ascomycetes. Edible and 
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medicinal mushrooms, which can be commercially produced, 
are cultivated on lignocellulosic agricultural residues such as 
straw, wood chips, and sawdust.[1]
Mushrooms have been used by humans since thousands of 
years as food and/or as medicine. More than 14,000 species of 
mushrooms are recognized, and among them, approximately 2000 
are identified as edible.[2] Of the 2000 edible mushrooms in 30 
genera, 270 species are now considered as potential therapeutic or 
preventative agents that may ensure wellness of humans.[3] Today, 
the increasing consumption of mushrooms can be attributed not 
only to the pleasant flavor and aroma of culinary mushrooms but 
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also to the current search for natural products, which are free of 
pesticides; food as nutraceuticals or functional food with high 
vitamins and protein contents as well bioactive activities including 
antioxidant activities.[4] The culinary mushrooms can be excellent 
components in our daily diet, because they are rich in proteins, 
fibers, carbohydrates, vitamins, and minerals. While at the same 
time, mushrooms are low in calories and fats including choles-
terol. In the recent years to unravel the mysteries of mushrooms, 
especially those used in traditional medicines, mushrooms are 
being investigated for their many ethnomycological claims of 
medicinal value. The mushrooms are being developed as nutra-
ceuticals or nutriceuticals to garner the essence of mushrooms 
and to make consumption easy. Further, scientific validation of 
traditional knowledge bears evidence of the many positive effects 
of consuming mushrooms fresh or processed on human health.[2] 
In the words of Chang:[5]
‘Without leaves, without buds, without flowers; 
Yet they form fruit. 
As a Food, as a tonic, as a medicine; 
The entire creation is precious.’ 
As the recognition of mushrooms as possible food or 
supplements that can improve health and enhance quality of 
life increases, numerous products are marketed with claims 
often based on ethnomycological knowledge. In an attempt to 
scientifically validate the numerous claims of the health benefits 
of mushrooms, related research are being actively undertaken 
world-wide. However, at this moment, many of the studies on 
the efficacy of medicinal mushrooms that are available to the 
public are based on animal studies (usually in mice) or cultured 
cells. There is a need to show efficacy in humans via clinical 
trials.[6] In China, complementary and alternative medicine is 
permitted as an alternative therapy for life-debilitating dis-
eases, and mushroom nutriceuticals or mushroom functional 
foods are included in cancer and other life-threatening diseases 
management. One of the many diseases that threaten humans, 
neurodegenerative diseases can be very traumatic as one ages. 
Neurohealth is the concern for the predicted silver tsunami to 
hit humans – the aging tsunami is projected to be 80-90 million 
of 65 –plus population in 2050.[7] 
Why the concern? A large percentage of this aging popula-
tion (projected at about 80%) will have at least one chronic 
health-related diseases. Alzheimer and neurodegenerative 
diseases are high on the list of chronic diseases of the aged. 
Alzheimer’s disease is primarily a disorder of aging with loss of 
cognitive function. This disease is characterized biologically by 
the death of neurons in the forebrain, hippocampus, and cerebral 
cortex accompanied by the presence of amyloid deposition. 
Amyloid β protein participates in the induction of neuronal 
cell death and neuritic changes. The symptoms caused by the 
death of cholinergic neurons are treated with drugs that enhance 
neurotransmission at cholinergic synapses. The drugs include 
Aricept[R] by Pfizer, Exelon[R] by Novartis, Reminyl[R] by 
Janssen, and Cognex[R] by First Horizon. These drugs only 
delay further deterioration and do not reverse the damage 
done to cognitive functions. Another drug memantine (Forest 
Laboratories), which blocks the receptor for the glutamate 
neurotransmitter which may be responsible for the neurotox-
icity in Alzheimer’s disease, had temporary beneficial effects, 
too. We have to find preventative agents. In neurodegenerative 
diseases, once the clinical symptoms are manifested, it will be 
only possible to arrest or delay further degeneration process. 
The strategy will be to look for agents that slow down and 
prevent further damage to the vital cells involved. The search 
is now for small molecules that can cross the brain-blood and 
induce the production of nerve growth factor (NGF), a family 
of proteins responsible for maintenance, survival, and regenera-
tion of neurons during adult life. 
It has been shown that NGF absence caused an Alzheimer’s-
like symptom in the adult brain of mice. Prevention will be 
definitely better than cure. The preventative agent/s have to be 
part of our diet. We may have to turn to traditional knowledge 
that taps nature for medicine to prevent or reduce the severity 
of nerve-related diseases as we age. Many plants and spices 
such as turmeric are said to help. For example, in India, it is 
noted that Alzheimer among the older generation is not in 
alarming numbers. The regular consumption of spices includ-
ing turmeric and pepper may be the reason, and currently, this 
is actively been studied.
Mushrooms for nerve and brain health
Can mushrooms help here? Almost all culinary mushrooms 
are noted for their polysaccharide components, which play a 
role in stimulation of immune system and possible applications 
in cancer management. Many edible genera, however, are also 
noted for their specific activities. Among the special activities, 
a number of mushrooms including Sarcodon scabrosus, Gano-
derma lucidum, Grifola frondosa, and Hericium erinaceus are 
reported to have activities related to nerve and brain health. 
In this paper, the potentials of mushrooms as nutraceutical or 
nutriceuticals to help in the reduction or even prevention of 
age-related neurodegenerative diseases are discussed. Sarcodon 
scabrosus, a bitter mushroom, contains cyathane diterpenoids 
termed scabronines.[8] When rat pheochromocytoma cells 
(PC12) were treated with scabronines A and G, there was neu-
rite outgrowth.[8] Extracts of G. lucidium contained neuroactive 
compounds that induced neuronal differentiation and prevented 
NGF-dependent apoptosis of rat pheochromocytoma PC12 
neuronal cells. These effects are probably mediated through the 
Ras/Erk and cAMP-response element-binding protein (CREB) 
signaling pathways, because G. lucidum extracts induced phos-
phorylation of Erk 1, Erk 2, and CREB.[9] 
Hericium erinaceus triggers neurite outgrowth and 
regeneration of damaged nerves
The culinary mushroom that has been extensively studied 
for its neurohealth properties is H. erinaceus (Lion’s Mane 
mushroom). The polysaccharides in an aqueous extract of the 
Lion’s mane mushroom could induce neuronal differentia-
tion and promote neuronal survival.[10] The chemical profile 
of extracts of this mushroom has been actively studied and 
reported by Kawagishi and co-researchers. Extracts of H. 
erinaceus induced the expression of neurotrophic factors 
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such as NGF in astrocytes.[11,12] In their studies, hericenones 
were isolated from the fruiting bodies of Lion’s mane while 
erinacines were isolated from the mycelium of the mushroom. 
Endoplasmic reticulum stress - attenuating compounds and 
dilinoleoyl phosphatidylethanolamine, a phospholipid with 
linoleic acid, an unsaturated fatty acid, purified from extracts 
of dried fruiting bodies of H. erinaceus, reduce endoplasmic 
reticulum stress-induced cell death. This may reduce the 
risk of neurodegenerative disease-induced cell death.[13] Fu-
jiwara et al.[14] investigated the neuroprotective effect of H. 
erinaceus on the ischemic brain damage in a middle cerebral 
artery occlusion model in mice. Hericium erinaceus (300 mg/
kg, continuously fed for 14 days after surgery) significantly 
decreased the size of the cerebral infarcts one day after the 
occlusion. In another study, a double-blind trial was conducted 
with 50- to 80-year-old Japanese men and women diagnosed 
with mild cognitive impairment in order to examine the ef-
ficacy of oral administration of H. erinaceus, for improv-
ing cognitive impairment, using a cognitive function scale 
based on the revised Hasegawa Dementia Scale (HDS-R).[15] 
The subjects in the H. erinaceus group took four 250 mg tablets 
containing 96% of Yamabushitake dry powder three times a 
day for 16 weeks. Cognitive function scale scores increased 
with the duration of intake. Laboratory tests showed no ad-
verse effect of H. erinaceus. The study suggested that H. eri-
naceus is effective in improving mild cognitive impairment.[15] 
Extracts of H. erinaceus induced phosphorylation of c-Jun 
N-terminal kinase (JNK) and its downstream substrate c-Jun, 
and increased c-Fos expression, suggesting that H. erinaceus 
promotes nerve growth factor gene expression via JNK signal-
ing.[16] Furthermore, the efficacy of H. erinaceus in vivo has 
been examined. Mice given feed regime containing 5% (w/w) 
H. erinaceus dry powder for seven days showed an increase 
in the level of NGF mRNA expression in the hippocampus.[16]
These studies are very encouraging, and the consumption 
of H. erinaceus-fresh or processed is acceptable. There are 
many preparations available off the counter. However, there 
should be guidelines and monitoring to ensure safety, efficacy, 
and other parameters to ensure that these preparations are 
functional as claimed. The best option will be consumption of 
fresh mushrooms. The processing has been reported to affect 
the neurite stimulatory activity of H. erinaceus.[17,18] Cultivation 
techniques and conditions may affect the medicinal properties 
of mushrooms too. Though Hericium erinaceus is a temperate 
mushroom, it can be cultivated in Malaysia, a tropical country. 
Hericium erinaceus (Plate 1a) cultivation in Malaysia is still 
in its infancy. The consumers at large do not know the potential 
of this rather strange-looking mushroom. Realizing the potential 
of this mushroom, research on the locally grown mushroom 
will help spearhead the growing as well as the consumption of 
this mushroom in Malaysia.
The stimulation of neurite extension using in vitro model 
using NG 108-15 cells by H. erinaceus grown in hot climate 
was investigated. Though the mushroom is now grown at higher 
temperatures, the unique property of this mushroom is retained. 
In fact, there was no difference in the neurite outgrowth stimu-
latory activity between the low- and high temperature-grown 
mushrooms.[19] However, the post-harvest processing technique 
does affect the activity.[17-19] This is very important to note, as the 
commercially available H. erinaceus is oven- dried to increase 
its shelf life. The extracts of the fruiting bodies dried in an oven 
was demonstrated to have lost their ability to stimulate neurite 
outgrowth [Figure 1].[19]
In another study, it was shown that extracts of H. erinaceus 
can enhance the activity of NGF in NG108-15 cells. A combi-
nation of 10 ng/ml NGF with 10 µg/ml H. erinaceus aqueous 
extract induced the highest percentage increase of 59.5 ± 5.0% 
neurite outgrowth compared to untreated neural cells (Lai et al., 
2012, unpublished). The effect of neurite outgrowth stimula-
tion was enhanced in this combined mixture when compared 
to the concentration of extract or NGF applied individually. 
The neurite outgrowth stimulation activity increased approxi-
mately 1.2-fold when compared to treatment with only 10 ng/
ml NGF (Lai et al., 2012, unpublished). At higher concentra-
tions, however, the enhancement of neurite stimulation activity 
of the aqueous mushroom extract and NGF was not observed. 
Further, early observations of an on-going study showed that 
the mushroom extract triggered NGF secretion in the presence 
of small amounts of NGF. Can this mushroom be then the secret 
to brain health? The direct extrapolation of in vitro results is not 
possible. Further studies, especially on mechanism of action at 
biochemical and molecular levels, are important. This far, there 
are no reports on toxicity due to long-term consumption of the 
mushroom. Further, a number of reported studies showed that 
Figure 1. The effects of an aqueous extract of fruiting bodies of H. erinaceus grown in a tropical climate. a: Negative control (without treatment); b: 
NGF (20 ng/ml); c: Aqueous extract of H. erinaceus (extensive neurite outgrowth)
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this mushroom has potential to be developed into a functional 
food. The processing techniques, however, have to be optimized 
so that maximum activity will be retained to enhance nerve 
health and possibly nerve regeneration.
Peripheral nerve injury leads to changes at the axonal site of 
injury and remotely in the dorsal root ganglia (DRG) contain-
ing cell bodies of sensory afferent neurons. The regenerative 
ability of injured axons depends on their capacity to locally 
synthesize new proteins and to degrade others at the injury site 
autonomously from the cell body. Nerve crush injury is a well-
established axonotmetic model in experimental regeneration 
studies to investigate the impact of various pharmacological 
treatments.[20,21] Further, axonal protein synthesis in the nor-
mal and injured peroneal nerves was examined. The results 
indicated that the intensity of nuclear ribonucleoprotein at the 
injured segments of crushed nerves in rats of treated groups 
was significantly higher than in negative control group. This 
suggests that local axonal protein synthesis machinery underlies 
growth cone initiation after injury. In addition, the principal 
signaling pathways that have been demonstrated to be involved 
in axon regeneration are protein kinase B (Akt) and mitogen-
activated protein kinase (MAPK). Akt cascade plays a major 
role in mediating neurotrophin-promoted cell survival while 
MAPK cascade is involved in mediating neurite outgrowth. A 
subfamily of MAPK, extracellular signal-regulated kinases 1 
and 2 (ERK1/2), controls cellular differentiation and prolifera-
tion. Double-labeling immunofluorescence studies showed that 
small neurons in L5 DRG ipsilateral to the crush injury in rats 
of treated groups expressed higher immunoreactivities for Akt 
and ERK1/2 compared to negative control group.[22] These data 
suggest that daily oral administration of aqueous extract of H. 
erinaceus fresh fruiting bodies could promote the regeneration 
of injured rat peripheral nerve in the early stages of recovery.[23] 
Hericium erinaceus, the mushroom associated with brain and 
nerve health, has been well-studied,[23] and preparations are 
available. However, there is a paucity of clinical trials to en-
dorse its potential in mitigating / delaying neurodegenerative 
disorders. Further, this mushroom may not be the only one that 
has beneficial effects on nerve and brain health.
Exploring neurotrophic mushrooms in traditional 
knowledge
To tap the indigenous knowledge in the utilization of the mac-
rofungal diversity of Malaysia as food and medicine, the diversity 
of potential mushrooms used by the indigenous communities are 
being explored for neurohealth. Three mushrooms were selected 
– Lignosus rhinocerotis (Cooke) Ryvarden (Plate1d); Ganoderma 
neo-japonicum Imazeki (Plate1e) and Pleurotus giganteus (Berk.) 
Karunarathna and K.D. Hyde (Plate 1b)
Based on indigenous knowledge, selected mushrooms have 
been used to prepare infusions that are believed to improve vital-
ity, increase alertness and overall wellness of the individual.[24] 
One such mushroom is Lignosus rhinocerotis.[25] The sclerotium 
of L. rhinocerotis (known as tiger milk mushroom) is taken daily 
or when needed in small amounts to ‘increase energy’ by the 
indigenous people of Malaysia. A national treasure mushroom, 
L. rhinocerotis, has been used to treat variety ailments by local 
and indigenous communities in Malaysia.[26] The mushroom is 
harvested in the wild and is believed in folklore that it grows where 
the tiger has spilled its milk. The mushroom, which is rarely en-
countered in the wild, has now been successfully domesticated.[25] 
In on-going in vitro investigations, an aqueous extract of the 
sclerotium of L. rhinocerotis induced neurite outgrowths of 
24.4% and 42.1% at 20 µg/ml (w/v) of aqueous extract alone and 
a combination of 20 µg/ml (w/v) aqueous extract and 30 ng/ml 
(w/v) of NGF, respectively, in rat pheochromocytoma cells (PC-
12Adh). Further, a combination of NGF and sclerotium extract 
had additive effects and enhanced neurite outgrowth.[27] Neuronal 
differentiation was confirmed by indirect immunofluorescence of 
neurofilament protein. To our knowledge, this is the first report on 
neurite-stimulating activities of L. rhinocerotis, and it may be a po-
tential mushroom to develop nerve and brain health nutraceuticals 
or nutriceuticals. However, studies on the chemical components 
will shed light on this possibility. There are on-going studies to 
determine the chemical components involved and the mechanisms 
of activity that trigger neurite outgrowth. 
Another interesting mushroom frequently used by indig-
enous communities is Ganoderma neo-japonicum. The mush-
room was boiled, and the decoction was consumed to treat 
fever, epilepsy and to improve body strength (Tan et al., 2012, 
unpublished). The neurite outgrowth stimulation activity of 
aqueous extracts of the fruiting bodies of G. lucidum (Plate 1c) 
and G. neo-japonicum were investigated. Varying concentra-
tions of the mushrooms and 50 ng/mL (w/v) of NGF as positive 
control was added to PC-12Adh cells. Aqueous extract of G. 
neo-japonicum showed the highest percentage [Figure 2] of 
Figure 2. The morphology of PC-12Adh cells. Arrows indicate neurite extensions. a: Negative control - F-12K medium only; b: Positive control - 50 
ng/mL (w/v) of NGF; c: 50 μg/mL of G. neo-japonicum
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neurite-bearing cells of 14.05 ± 0.66% at 50 µg/mL (w/v), fol-
lowed by G. lucidum (12.08 ± 0.85%) at a higher concentration 
of 75 µg/mL (w/v). The percentage of neurite-bearing cells 
of G. neo-japonicum obtained with 50 µg/mL (w/v) was 73% 
higher compared to the positive control. It was proposed that G. 
neo-japonicum contained NGF-like bioactive compound/s for 
maintaining and rebuilding the neural communications network 
that may help to prevent neurodegenerative diseases (Syntyche 
Ling et al., 2012, unpublished) [Figure 3 and 4].
Pleurotus giganteus (Berk.) Karunarathna and K.D. Hyde 
formerly known as Panus/Lentinus giganteus is a popular mush-
room consumed by indigenous communities in Malaysia.[28] A 
Plate 1. Selected culinary and medicinal medicinal mushrooms with neurite outgrowth stimulatory activity. a: H. erinaceus; b: P. giganteus; c: G. 
lucidium; d: L. rhinocerotis; d: G.neo-japonicum
Figure 3. Neurofilament staining to confirm neurite outgrowth
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variety domesticated in China is being grown in Malaysia, and it 
is a very popular culinary mushroom and has a nutritional profile 
that warrants its inclusion in human diets.[29] The fruiting bodies 
of P. giganteus contained per gm per 100 gm: 67.2 carbohydrate, 
15.4 protein, and 33.3 dietary fiber. It was rich in minerals like 
magnesium and potassium. To our knowledge, the medicinal 
benefits, if any, are yet to be explored. Recently, it was reported 
to have hepato-protective effects.[30] An aqueous extract at 25 µg/
ml had a significant (P < 0.05) effect (31.7 ± 1.1%) in stimulating 
neuronal differentiation compared to 50 ng/ml of NGF (28.3 ± 
0.4%).[29] The high potassium level in the fruiting bodies and the 
presence of bioactive compounds (mainly triterpenoids) could be 
responsible for the neuronal stimulatory activity. The chemical 
identity responsible for the activity has to be identified. This may 
lead to treatment regimes in partially impaired cognitive functions 
in patients. Further, in the on-going study, it was observed that 
neurite outgrowth stimulated by P. giganteus was mediated via the 
“cross-talk” between MEK/ERKs and PI3K/Akt pathways. The 
mushroom may be a candidate for the development of functional 
food to reduce or prevent severity of age-related neurodegenera-
tive diseases. Prevention is preferred for this traumatic disorder; 
once the symptoms are clinically apparent, the reversal is almost 
impossible.
CONCLUSION
The studies done by many researchers as well as on-going 
studies show that selected mushrooms do have neurotrophic 
properties that can be beneficial to humans. Regular consump-
tion may promote nerve and brain health. This is particularly 
useful during injury (as in an accidents) or as we age. Further, 
there is a need to study the potential mushrooms to elucidate 
their mechanisms of activities as well as clinical trials. This far, 
only H. erinaceus has been extensively studied. The identifica-
tion of more varieties of mushroom with these unique properties 
may contribute to identifying novel chemical agents that can 
have preventative or therapeutic functions.
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